These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genomic and prognostic heterogeneity among RAS/BRAF Berg KCG; Brunsell TH; Sveen A; Alagaratnam S; Bjørnslett M; Hektoen M; Brudvik KW; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA Mol Oncol; 2021 Apr; 15(4):830-845. PubMed ID: 33325154 [TBL] [Abstract][Full Text] [Related]
3. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients. Ye JX; Liu Y; Qin Y; Zhong HH; Yi WN; Shi XY World J Gastroenterol; 2015 Feb; 21(5):1595-605. PubMed ID: 25663779 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and molecular characterization of deficient mismatch repair colorectal cancer. Yamada A; Yamamoto Y; Minamiguchi S; Kamada M; Sunami T; Ohashi S; Seno H; Kawada K; Muto M Hum Pathol; 2022 Dec; 130():1-9. PubMed ID: 36150551 [TBL] [Abstract][Full Text] [Related]
5. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages. Li W; Qiu T; Zhi W; Shi S; Zou S; Ling Y; Shan L; Ying J; Lu N BMC Cancer; 2015 May; 15():340. PubMed ID: 25929517 [TBL] [Abstract][Full Text] [Related]
6. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer. Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237 [TBL] [Abstract][Full Text] [Related]
7. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features. Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188 [TBL] [Abstract][Full Text] [Related]
8. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727 [TBL] [Abstract][Full Text] [Related]
9. Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas. Jesinghaus M; Konukiewitz B; Keller G; Kloor M; Steiger K; Reiche M; Penzel R; Endris V; Arsenic R; Hermann G; Stenzinger A; Weichert W; Pfarr N; Klöppel G Mod Pathol; 2017 Apr; 30(4):610-619. PubMed ID: 28059096 [TBL] [Abstract][Full Text] [Related]
10. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival. Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419 [TBL] [Abstract][Full Text] [Related]
11. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506 [TBL] [Abstract][Full Text] [Related]
12. Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer. Kawaguchi M; Yanokura M; Banno K; Kobayashi Y; Kuwabara Y; Kobayashi M; Nomura H; Hirasawa A; Susumu N; Aoki D Int J Oncol; 2009 Jun; 34(6):1541-7. PubMed ID: 19424571 [TBL] [Abstract][Full Text] [Related]
14. Frequency and coexistence of KRAS, NRAS, BRAF and PIK3CA mutations and occurrence of MMR deficiency in Danish colorectal cancer patients. Poulsen TS; de Oliveira DVNP; Espersen MLM; Klarskov LL; Skovrider-Ruminski W; Hogdall E APMIS; 2021 Feb; 129(2):61-69. PubMed ID: 33075161 [TBL] [Abstract][Full Text] [Related]
15. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas. Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990 [TBL] [Abstract][Full Text] [Related]
16. Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases. Alhamar M; Tudor Vladislav I; Smith SC; Gao Y; Cheng L; Favazza LA; Alani AM; Ittmann MM; Riddle ND; Whiteley LJ; Gupta NS; Carskadon S; Gomez-Gelvez JC; Chitale DA; Palanisamy N; Hes O; Trpkov K; Williamson SR Histopathology; 2020 Dec; 77(6):890-899. PubMed ID: 32639612 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Chang DT; Pai RK; Rybicki LA; Dimaio MA; Limaye M; Jayachandran P; Koong AC; Kunz PA; Fisher GA; Ford JM; Welton M; Shelton A; Ma L; Arber DA; Pai RK Mod Pathol; 2012 Aug; 25(8):1128-39. PubMed ID: 22481281 [TBL] [Abstract][Full Text] [Related]
18. Colorectal adenosquamous carcinoma: Peculiar morphologic features and distinct immunoprofiles in squamous and glandular components. Parente P; Mastracci L; Vanoli A; Businello G; Paudice M; Angerilli V; Castelvetere M; Graziano P; Fassan M; Grillo F Pathol Res Pract; 2022 Aug; 236():153967. PubMed ID: 35662040 [TBL] [Abstract][Full Text] [Related]
19. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180 [TBL] [Abstract][Full Text] [Related]
20. Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing. Cushman-Vokoun AM; Stover DG; Zhao Z; Koehler EA; Berlin JD; Vnencak-Jones CL Clin Colorectal Cancer; 2013 Sep; 12(3):168-78. PubMed ID: 23773459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]